- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Immobilier
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 205 results
Webinar
octobre 26, 2023
Navigating the Foreign Agents Registration Act (FARA): Where is DOJ Headed?
Webinar
octobre 26, 2023
An Update on No Surprises Act Implementation and Developments on the Hospital Price Transparency Rule
Webinar
octobre 10, 2023
Key Food and Beverage Issues: Recent Developments in False Advertising Litigation in the U.S and the European Union
Webinar
septembre 27, 2023
At Last! FDA Issues Final Guidance on Use of Real-World Evidence for Regulatory Decision-Making for Drug and Biological Products
Webinar
septembre 19, 2023
2023 IPPS Final Rule: Analysis and Opportunity
Webinar
août 29, 2023
Investigations & Enforcement Developments for Life Sciences and Healthcare Companies
Webinar
juillet 25, 2023
Insider Trading and the Life Sciences – Recent Developments and Potential Pitfalls for Pharmaceutical, Medical Device, and Life Sciences Companies
Webinar
juillet 11, 2023
Virtual Talk im Turm – Update MiFID III: Retail Investment Package
Webinar
juin 20, 2023
New Developments in Regulatory Review Requirements for Healthcare M&A Transactions
Webinar
juin 8, 2023
Are You Ready? The New FDA Requirement for Diversity Action Plans in Drug and Device Clinical Investigations
Webinar
mai 10, 2023
Talk im Turm – Parallel Import: ECJ Reboxing vs. Relabeling Decision
Webinar
avril 20, 2023
Revision of the EU Pharmaceutical Legislation - What To Expect